Inventor
MITCHELL STEPHEN CHAPPELL
US15 patents
⚠️ This page may combine multiple inventors who share the name “MITCHELL STEPHEN CHAPPELL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGENSYS INC
14 patentsUS6329503B1Dec 11, 2001
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC147 citations99
US7485299B2Feb 3, 2009
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC49 citations96
US7053186B2May 30, 2006
Antibodies immunospecific for STEAP1
AGENSYS INC48 citations96
US6887975B2May 3, 2005
Peptides derived from STEAP1
AGENSYS INC40 citations96
US6833438B1Dec 21, 2004
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC45 citations96
US7968307B2Jun 28, 2011
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC14 citations92
US7928201B2Apr 19, 2011
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC16 citations92
US7642054B2Jan 5, 2010
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC19 citations92
US7611904B2Nov 3, 2009
Serpentine transmembrane antigens expressed in human cancers and uses thereof
AGENSYS INC19 citations92
US6509458B1Jan 21, 2003
Gene expressed in prostate cancer
AGENSYS INC19 citations92
US8053551B2Nov 8, 2011
Serpentine transmembrane antigens expressed in human cancers and uses therefor
AGENSYS INC7 citations84
US6652859B1Nov 25, 2003
PTANS: testis specific proteins expressed in prostate cancer
AGENSYS INC9 citations74
US7803916B2Sep 28, 2010
Gene expressed in prostate cancer
AGENSYS INC0 citations52
US7432346B2Oct 7, 2008
Gene expressed in prostate cancer
AGENSYS INC0 citations52